Propanc Biopharma, Inc. — Director's Dealing 2012

Aug 24, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Propanc Health Group Corp (PPCH)
CIK: 0001517681
Period of Report: 2012-08-23

Reporting Person: Nathanielsz James Andrew (Director, Chief Executive Officer, 10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-08-23	Common Stock	P	250000	$0.20	Disposed	9782261	Indirect